The authors hypothesize that tobacco smoking-generated inflammation polarizes CD4+ CM and CD4+ EM cells that may contribute to the exacerbation of COPD and impairment of tumor-protective immunity in NSCLC. Here, CD4 is linked to non-small cell lung carcinoma.